ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya, Julia, Allison R Baker, Frank J Slack, and Pilar Santisteban. 2020. “ADAR1-Mediated RNA Editing Is a Novel Oncogenic Process in Thyroid Cancer and Regulates MiR-200 Activity.”. Oncogene 39 (18): 3738-53.